aluates Reports

$ 29300.0

Automative

Global Subcutaneous Injection Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-11Q6180

Global Subcutaneous Injection Market Insights and Forecast to 2028

BUY CHAPTERS

Global Subcutaneous Injection Market Research Report 2025

Code: QYRE-Auto-11Q6180

Report

September 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Becton Dickinson

Daiichi Sankyo

Sanofi

Roche

GSK

Eli Lilly

Asahi Kasei Pharma

Takeda Pharmaceutical

Antares Pharma, Inc.

Eisai Co Ltd

Chugai Pharmaceutical

Endo International

Penjet Corporation

Aspen Medical Group

Subcutaneous Injection Market

The global market for Subcutaneous Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine and goserelin. Subcutaneous, as opposed to intravenous, injection of recreational drugs is referred to as "skin popping". Subcutaneous administration may be abbreviated as SC, SQ, sub-cu, sub-Q, SubQ, or subcut. Subcut is the preferred abbreviation for patient safety.

North American market for Subcutaneous Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Subcutaneous Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Subcutaneous Injection in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Subcutaneous Injection include Becton Dickinson, Daiichi Sankyo, Sanofi, Roche, GSK, Eli Lilly, Asahi Kasei Pharma, Takeda Pharmaceutical, Antares Pharma, Inc., Eisai Co.，Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Subcutaneous Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Injection.

The Subcutaneous Injection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Subcutaneous Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Subcutaneous Injection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Subcutaneous Injection Market Report

Report Metric	Details
Report Name	Subcutaneous Injection Market
Segment by Type	Subcutaneous Injection Equipment Subcutaneous Injection Drug Others
Segment by Application	Hospital Clinic Laboratory Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Becton Dickinson, Daiichi Sankyo, Sanofi, Roche, GSK, Eli Lilly, Asahi Kasei Pharma, Takeda Pharmaceutical, Antares Pharma, Inc., Eisai Co.，Ltd, Chugai Pharmaceutical, Endo International, PenJet Corporation, Aspen Medical Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Subcutaneous Injection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Subcutaneous Injection Market report?

Ans: The main players in the Subcutaneous Injection Market are Becton Dickinson, Daiichi Sankyo, Sanofi, Roche, GSK, Eli Lilly, Asahi Kasei Pharma, Takeda Pharmaceutical, Antares Pharma, Inc., Eisai Co.，Ltd, Chugai Pharmaceutical, Endo International, PenJet Corporation, Aspen Medical Group

What are the Application segmentation covered in the Subcutaneous Injection Market report?

Ans: The Applications covered in the Subcutaneous Injection Market report are Hospital, Clinic, Laboratory, Others

What are the Type segmentation covered in the Subcutaneous Injection Market report?

Ans: The Types covered in the Subcutaneous Injection Market report are Subcutaneous Injection Equipment, Subcutaneous Injection Drug, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Subcutaneous Injection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Subcutaneous Injection Equipment

1.2.3 Subcutaneous Injection Drug

1.2.4 Others

1.3 Market by Application

1.3.1 Global Subcutaneous Injection Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Laboratory

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Subcutaneous Injection Market Perspective (2020-2031)

2.2 Global Subcutaneous Injection Growth Trends by Region

2.2.1 Global Subcutaneous Injection Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Subcutaneous Injection Historic Market Size by Region (2020-2025)

2.2.3 Subcutaneous Injection Forecasted Market Size by Region (2026-2031)

2.3 Subcutaneous Injection Market Dynamics

2.3.1 Subcutaneous Injection Industry Trends

2.3.2 Subcutaneous Injection Market Drivers

2.3.3 Subcutaneous Injection Market Challenges

2.3.4 Subcutaneous Injection Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Subcutaneous Injection Players by Revenue

3.1.1 Global Top Subcutaneous Injection Players by Revenue (2020-2025)

3.1.2 Global Subcutaneous Injection Revenue Market Share by Players (2020-2025)

3.2 Global Subcutaneous Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Subcutaneous Injection Revenue

3.4 Global Subcutaneous Injection Market Concentration Ratio

3.4.1 Global Subcutaneous Injection Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Subcutaneous Injection Revenue in 2024

3.5 Global Key Players of Subcutaneous Injection Head office and Area Served

3.6 Global Key Players of Subcutaneous Injection, Product and Application

3.7 Global Key Players of Subcutaneous Injection, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Subcutaneous Injection Breakdown Data by Type

4.1 Global Subcutaneous Injection Historic Market Size by Type (2020-2025)

4.2 Global Subcutaneous Injection Forecasted Market Size by Type (2026-2031)

5 Subcutaneous Injection Breakdown Data by Application

5.1 Global Subcutaneous Injection Historic Market Size by Application (2020-2025)

5.2 Global Subcutaneous Injection Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Subcutaneous Injection Market Size (2020-2031)

6.2 North America Subcutaneous Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Subcutaneous Injection Market Size by Country (2020-2025)

6.4 North America Subcutaneous Injection Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Subcutaneous Injection Market Size (2020-2031)

7.2 Europe Subcutaneous Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Subcutaneous Injection Market Size by Country (2020-2025)

7.4 Europe Subcutaneous Injection Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Subcutaneous Injection Market Size (2020-2031)

8.2 Asia-Pacific Subcutaneous Injection Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Subcutaneous Injection Market Size by Region (2020-2025)

8.4 Asia-Pacific Subcutaneous Injection Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Subcutaneous Injection Market Size (2020-2031)

9.2 Latin America Subcutaneous Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Subcutaneous Injection Market Size by Country (2020-2025)

9.4 Latin America Subcutaneous Injection Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Subcutaneous Injection Market Size (2020-2031)

10.2 Middle East & Africa Subcutaneous Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Subcutaneous Injection Market Size by Country (2020-2025)

10.4 Middle East & Africa Subcutaneous Injection Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Becton Dickinson

11.1.1 Becton Dickinson Company Details

11.1.2 Becton Dickinson Business Overview

11.1.3 Becton Dickinson Subcutaneous Injection Introduction

11.1.4 Becton Dickinson Revenue in Subcutaneous Injection Business (2020-2025)

11.1.5 Becton Dickinson Recent Development

11.2 Daiichi Sankyo

11.2.1 Daiichi Sankyo Company Details

11.2.2 Daiichi Sankyo Business Overview

11.2.3 Daiichi Sankyo Subcutaneous Injection Introduction

11.2.4 Daiichi Sankyo Revenue in Subcutaneous Injection Business (2020-2025)

11.2.5 Daiichi Sankyo Recent Development

11.3 Sanofi

11.3.1 Sanofi Company Details

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Subcutaneous Injection Introduction

11.3.4 Sanofi Revenue in Subcutaneous Injection Business (2020-2025)

11.3.5 Sanofi Recent Development

11.4 Roche

11.4.1 Roche Company Details

11.4.2 Roche Business Overview

11.4.3 Roche Subcutaneous Injection Introduction

11.4.4 Roche Revenue in Subcutaneous Injection Business (2020-2025)

11.4.5 Roche Recent Development

11.5 GSK

11.5.1 GSK Company Details

11.5.2 GSK Business Overview

11.5.3 GSK Subcutaneous Injection Introduction

11.5.4 GSK Revenue in Subcutaneous Injection Business (2020-2025)

11.5.5 GSK Recent Development

11.6 Eli Lilly

11.6.1 Eli Lilly Company Details

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly Subcutaneous Injection Introduction

11.6.4 Eli Lilly Revenue in Subcutaneous Injection Business (2020-2025)

11.6.5 Eli Lilly Recent Development

11.7 Asahi Kasei Pharma

11.7.1 Asahi Kasei Pharma Company Details

11.7.2 Asahi Kasei Pharma Business Overview

11.7.3 Asahi Kasei Pharma Subcutaneous Injection Introduction

11.7.4 Asahi Kasei Pharma Revenue in Subcutaneous Injection Business (2020-2025)

11.7.5 Asahi Kasei Pharma Recent Development

11.8 Takeda Pharmaceutical

11.8.1 Takeda Pharmaceutical Company Details

11.8.2 Takeda Pharmaceutical Business Overview

11.8.3 Takeda Pharmaceutical Subcutaneous Injection Introduction

11.8.4 Takeda Pharmaceutical Revenue in Subcutaneous Injection Business (2020-2025)

11.8.5 Takeda Pharmaceutical Recent Development

11.9 Antares Pharma, Inc.

11.9.1 Antares Pharma, Inc. Company Details

11.9.2 Antares Pharma, Inc. Business Overview

11.9.3 Antares Pharma, Inc. Subcutaneous Injection Introduction

11.9.4 Antares Pharma, Inc. Revenue in Subcutaneous Injection Business (2020-2025)

11.9.5 Antares Pharma, Inc. Recent Development

11.10 Eisai Co.，Ltd

11.10.1 Eisai Co.，Ltd Company Details

11.10.2 Eisai Co.，Ltd Business Overview

11.10.3 Eisai Co.，Ltd Subcutaneous Injection Introduction

11.10.4 Eisai Co.，Ltd Revenue in Subcutaneous Injection Business (2020-2025)

11.10.5 Eisai Co.，Ltd Recent Development

11.11 Chugai Pharmaceutical

11.11.1 Chugai Pharmaceutical Company Details

11.11.2 Chugai Pharmaceutical Business Overview

11.11.3 Chugai Pharmaceutical Subcutaneous Injection Introduction

11.11.4 Chugai Pharmaceutical Revenue in Subcutaneous Injection Business (2020-2025)

11.11.5 Chugai Pharmaceutical Recent Development

11.12 Endo International

11.12.1 Endo International Company Details

11.12.2 Endo International Business Overview

11.12.3 Endo International Subcutaneous Injection Introduction

11.12.4 Endo International Revenue in Subcutaneous Injection Business (2020-2025)

11.12.5 Endo International Recent Development

11.13 PenJet Corporation

11.13.1 PenJet Corporation Company Details

11.13.2 PenJet Corporation Business Overview

11.13.3 PenJet Corporation Subcutaneous Injection Introduction

11.13.4 PenJet Corporation Revenue in Subcutaneous Injection Business (2020-2025)

11.13.5 PenJet Corporation Recent Development

11.14 Aspen Medical Group

11.14.1 Aspen Medical Group Company Details

11.14.2 Aspen Medical Group Business Overview

11.14.3 Aspen Medical Group Subcutaneous Injection Introduction

11.14.4 Aspen Medical Group Revenue in Subcutaneous Injection Business (2020-2025)

11.14.5 Aspen Medical Group Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Becton Dickinson

Daiichi Sankyo

Sanofi

Roche

GSK

Eli Lilly

Asahi Kasei Pharma

Takeda Pharmaceutical

Antares Pharma, Inc.

Eisai Co Ltd

Chugai Pharmaceutical

Endo International

Penjet Corporation

Aspen Medical Group

List of Tables

Table 1. Global Subcutaneous Injection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Subcutaneous Injection Equipment

Table 3. Key Players of Subcutaneous Injection Drug

Table 4. Key Players of Others

Table 5. Global Subcutaneous Injection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Subcutaneous Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Subcutaneous Injection Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Subcutaneous Injection Market Share by Region (2020-2025)

Table 9. Global Subcutaneous Injection Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Subcutaneous Injection Market Share by Region (2026-2031)

Table 11. Subcutaneous Injection Market Trends

Table 12. Subcutaneous Injection Market Drivers

Table 13. Subcutaneous Injection Market Challenges

Table 14. Subcutaneous Injection Market Restraints

Table 15. Global Subcutaneous Injection Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Subcutaneous Injection Market Share by Players (2020-2025)

Table 17. Global Top Subcutaneous Injection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Injection as of 2024)

Table 18. Ranking of Global Top Subcutaneous Injection Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Subcutaneous Injection Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Subcutaneous Injection, Headquarters and Area Served

Table 21. Global Key Players of Subcutaneous Injection, Product and Application

Table 22. Global Key Players of Subcutaneous Injection, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Subcutaneous Injection Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Subcutaneous Injection Revenue Market Share by Type (2020-2025)

Table 26. Global Subcutaneous Injection Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Subcutaneous Injection Revenue Market Share by Type (2026-2031)

Table 28. Global Subcutaneous Injection Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Subcutaneous Injection Revenue Market Share by Application (2020-2025)

Table 30. Global Subcutaneous Injection Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Subcutaneous Injection Revenue Market Share by Application (2026-2031)

Table 32. North America Subcutaneous Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Subcutaneous Injection Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Subcutaneous Injection Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Subcutaneous Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Subcutaneous Injection Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Subcutaneous Injection Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Subcutaneous Injection Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Subcutaneous Injection Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Subcutaneous Injection Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Subcutaneous Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Subcutaneous Injection Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Subcutaneous Injection Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Subcutaneous Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Subcutaneous Injection Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Subcutaneous Injection Market Size by Country (2026-2031) & (US$ Million)

Table 47. Becton Dickinson Company Details

Table 48. Becton Dickinson Business Overview

Table 49. Becton Dickinson Subcutaneous Injection Product

Table 50. Becton Dickinson Revenue in Subcutaneous Injection Business (2020-2025) & (US$ Million)

Table 51. Becton Dickinson Recent Development

Table 52. Daiichi Sankyo Company Details

Table 53. Daiichi Sankyo Business Overview

Table 54. Daiichi Sankyo Subcutaneous Injection Product

Table 55. Daiichi Sankyo Revenue in Subcutaneous Injection Business (2020-2025) & (US$ Million)

Table 56. Daiichi Sankyo Recent Development

Table 57. Sanofi Company Details

Table 58. Sanofi Business Overview

Table 59. Sanofi Subcutaneous Injection Product

Table 60. Sanofi Revenue in Subcutaneous Injection Business (2020-2025) & (US$ Million)

Table 61. Sanofi Recent Development

Table 62. Roche Company Details

Table 63. Roche Business Overview

Table 64. Roche Subcutaneous Injection Product

Table 65. Roche Revenue in Subcutaneous Injection Business (2020-2025) & (US$ Million)

Table 66. Roche Recent Development

Table 67. GSK Company Details

Table 68. GSK Business Overview

Table 69. GSK Subcutaneous Injection Product

Table 70. GSK Revenue in Subcutaneous Injection Business (2020-2025) & (US$ Million)

Table 71. GSK Recent Development

Table 72. Eli Lilly Company Details

Table 73. Eli Lilly Business Overview

Table 74. Eli Lilly Subcutaneous Injection Product

Table 75. Eli Lilly Revenue in Subcutaneous Injection Business (2020-2025) & (US$ Million)

Table 76. Eli Lilly Recent Development

Table 77. Asahi Kasei Pharma Company Details

Table 78. Asahi Kasei Pharma Business Overview

Table 79. Asahi Kasei Pharma Subcutaneous Injection Product

Table 80. Asahi Kasei Pharma Revenue in Subcutaneous Injection Business (2020-2025) & (US$ Million)

Table 81. Asahi Kasei Pharma Recent Development

Table 82. Takeda Pharmaceutical Company Details

Table 83. Takeda Pharmaceutical Business Overview

Table 84. Takeda Pharmaceutical Subcutaneous Injection Product

Table 85. Takeda Pharmaceutical Revenue in Subcutaneous Injection Business (2020-2025) & (US$ Million)

Table 86. Takeda Pharmaceutical Recent Development

Table 87. Antares Pharma, Inc. Company Details

Table 88. Antares Pharma, Inc. Business Overview

Table 89. Antares Pharma, Inc. Subcutaneous Injection Product

Table 90. Antares Pharma, Inc. Revenue in Subcutaneous Injection Business (2020-2025) & (US$ Million)

Table 91. Antares Pharma, Inc. Recent Development

Table 92. Eisai Co.，Ltd Company Details

Table 93. Eisai Co.，Ltd Business Overview

Table 94. Eisai Co.，Ltd Subcutaneous Injection Product

Table 95. Eisai Co.，Ltd Revenue in Subcutaneous Injection Business (2020-2025) & (US$ Million)

Table 96. Eisai Co.，Ltd Recent Development

Table 97. Chugai Pharmaceutical Company Details

Table 98. Chugai Pharmaceutical Business Overview

Table 99. Chugai Pharmaceutical Subcutaneous Injection Product

Table 100. Chugai Pharmaceutical Revenue in Subcutaneous Injection Business (2020-2025) & (US$ Million)

Table 101. Chugai Pharmaceutical Recent Development

Table 102. Endo International Company Details

Table 103. Endo International Business Overview

Table 104. Endo International Subcutaneous Injection Product

Table 105. Endo International Revenue in Subcutaneous Injection Business (2020-2025) & (US$ Million)

Table 106. Endo International Recent Development

Table 107. PenJet Corporation Company Details

Table 108. PenJet Corporation Business Overview

Table 109. PenJet Corporation Subcutaneous Injection Product

Table 110. PenJet Corporation Revenue in Subcutaneous Injection Business (2020-2025) & (US$ Million)

Table 111. PenJet Corporation Recent Development

Table 112. Aspen Medical Group Company Details

Table 113. Aspen Medical Group Business Overview

Table 114. Aspen Medical Group Subcutaneous Injection Product

Table 115. Aspen Medical Group Revenue in Subcutaneous Injection Business (2020-2025) & (US$ Million)

Table 116. Aspen Medical Group Recent Development

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

Table 120. Authors List of This Report

List of Figures

Figure 1. Subcutaneous Injection Picture

Figure 2. Global Subcutaneous Injection Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Subcutaneous Injection Market Share by Type: 2024 VS 2031

Figure 4. Subcutaneous Injection Equipment Features

Figure 5. Subcutaneous Injection Drug Features

Figure 6. Others Features

Figure 7. Global Subcutaneous Injection Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Subcutaneous Injection Market Share by Application: 2024 VS 2031

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Laboratory Case Studies

Figure 12. Others Case Studies

Figure 13. Subcutaneous Injection Report Years Considered

Figure 14. Global Subcutaneous Injection Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Subcutaneous Injection Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Subcutaneous Injection Market Share by Region: 2024 VS 2031

Figure 17. Global Subcutaneous Injection Market Share by Players in 2024

Figure 18. Global Top Subcutaneous Injection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Injection as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Subcutaneous Injection Revenue in 2024

Figure 20. North America Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Subcutaneous Injection Market Share by Country (2020-2031)

Figure 22. United States Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Subcutaneous Injection Market Share by Country (2020-2031)

Figure 26. Germany Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Subcutaneous Injection Market Share by Region (2020-2031)

Figure 34. China Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Subcutaneous Injection Market Share by Country (2020-2031)

Figure 42. Mexico Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Subcutaneous Injection Market Share by Country (2020-2031)

Figure 46. Turkey Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Subcutaneous Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Becton Dickinson Revenue Growth Rate in Subcutaneous Injection Business (2020-2025)

Figure 50. Daiichi Sankyo Revenue Growth Rate in Subcutaneous Injection Business (2020-2025)

Figure 51. Sanofi Revenue Growth Rate in Subcutaneous Injection Business (2020-2025)

Figure 52. Roche Revenue Growth Rate in Subcutaneous Injection Business (2020-2025)

Figure 53. GSK Revenue Growth Rate in Subcutaneous Injection Business (2020-2025)

Figure 54. Eli Lilly Revenue Growth Rate in Subcutaneous Injection Business (2020-2025)

Figure 55. Asahi Kasei Pharma Revenue Growth Rate in Subcutaneous Injection Business (2020-2025)

Figure 56. Takeda Pharmaceutical Revenue Growth Rate in Subcutaneous Injection Business (2020-2025)

Figure 57. Antares Pharma, Inc. Revenue Growth Rate in Subcutaneous Injection Business (2020-2025)

Figure 58. Eisai Co.，Ltd Revenue Growth Rate in Subcutaneous Injection Business (2020-2025)

Figure 59. Chugai Pharmaceutical Revenue Growth Rate in Subcutaneous Injection Business (2020-2025)

Figure 60. Endo International Revenue Growth Rate in Subcutaneous Injection Business (2020-2025)

Figure 61. PenJet Corporation Revenue Growth Rate in Subcutaneous Injection Business (2020-2025)

Figure 62. Aspen Medical Group Revenue Growth Rate in Subcutaneous Injection Business (2020-2025)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Subcutaneous Vaccine Adjuvants Market Research Report 2025

Immune Globulin Subcutaneous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Subcutaneous Injection Immunoglobulin Market Insights Forecast to 2030

Global Subcutaneous Immunoglobulins Market Research Report 2025

Global On body Injectors Market Research Report 2025

Global Subcutaneous Implantable Cardioverter Defibrillator Market Research Report 2025

Global Intradermal Injection Device Market Research Report 2025

Global Subcutaneous Contraceptive Implants Market Research Report 2025

Global Aesthetics Intradermal Injection Devices Market Research Report 2024

Global Subcutaneous Tunnel Needle Market Research Report 2024

Global Subcutaneous Drug Delivery Devices Market Insights Forecast to 2030

Continuous Subcutaneous Insulin Infusion Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Submucosal Injections Market Research Report 2024

Global Submucosal Injection Agent Market Research Report 2025

Global Subcutaneous Implantable Defibrillators Market Research Report 2024

Global Needle Free Jet Injection System Market Research Report 2025

Global Jet Based Needle Free Injectors Market Research Report 2024

Needle free Insulin Syringe Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Subcutaneous Immunotherapy Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

Report Code:

QYRE-Auto-15U8132

Published:

Tue Jul 22 00:00:00 UTC 2025

Est. Total

$29300.0